Pangen Biotech Inc. (222110)

Overview

PanGen Biotech Inc., established in 1999 and headquartered in Suwon-si, South Korea, operates as a pioneering biologics firm within the region. The company specializes in the development of biosimilar products, a class of therapeutic solutions designed to be highly similar to already approved biologic drugs, offering an alternative to patients in need of more accessible biopharmaceutical options. PanGen Biotech Inc. extends its expertise beyond the development of biosimilars by providing comprehensive services including cell line development, GMP (Good Manufacturing Practice) production, and technology transfer services catering to the global biopharmaceutical industry.

Products and Services

• Biosimilar Products:

  PanGen Biotech Inc. is engaged in the development of a range of biosimilar products, including but not limited to EPO (Erythropoietin), recombinant factor VIII, and G-CSF (Granulocyte-Colony Stimulating Factor). These products are developed as cost-effective alternatives to existing biologic therapies, aiming to enhance patient access to critical treatments for various conditions like anemia, blood clotting disorders, and neutropenia.

• CHO Cell Lines for Proteins and Monoclonal Antibodies:

  The company leverages Chinese Hamster Ovary (CHO) cell lines, a gold standard in biopharmaceutical manufacturing, for the production of therapeutic proteins and monoclonal antibodies. This platform is pivotal for ensuring high-quality and efficacious biologic products.

• One-Stop Services:

  Offering a comprehensive range from producer cell line development to GMP production, PanGen Biotech Inc. supports its clients throughout the entire product lifecycle. This integrated approach facilitates the seamless transition of biopharmaceutical products from development to commercialization.

• Reagents, Quantitation Kits, and Cell-Based Assay Systems:

  Catering to the broader biotechnology and pharmaceutical industry, the company supplies an array of essential laboratory reagents, quantitation kits, and cell-based assay systems. These products are critical for research and development, enabling accurate measurement and analysis in various biological and pharmaceutical processes.

• Technology Transfer Service:

  In addition to its product offerings, PanGen Biotech Inc. provides technology transfer services, facilitating the sharing of proprietary technologies, processes, and manufacturing techniques with partnering organizations. This service ensures that advancements in biotechnology are widely accessible, fostering innovation across the biopharmaceutical industry.